Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus

NACompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

January 16, 2025

Primary Completion Date

August 16, 2025

Study Completion Date

August 16, 2025

Conditions
Status Epilepticus
Interventions
DRUG

Intravenous brivaracetam

Patients received intravenous brivaracetam as a loading dose of 2 mg/kg (maximum 100 mg) diluted in 100 ml of normal saline infused over 10 minutes.

DRUG

Intravenous levetiracetam

Patients received intravenous levetiracetam as a loading dose of 40 mg/kg (maximum 3000 mg) diluted in 100 ml of normal saline infused over 10 minutes.

Trial Locations (1)

66000

The Children's Hospital and Institute of Child Health, Multan

All Listed Sponsors
lead

Muhammad Aamir Latif

OTHER

NCT07163572 - Comparison of Intravenous Brivaracetam Versus Levetiracetam in the Management of Status Epilepticus | Biotech Hunter | Biotech Hunter